Product Categories
| Country: | China |
|---|---|
| Tel: | 010-010-52878169 |
| Mobile: | 15801002657 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Mometasone Furoate Impurity A | C27H29ClO5 | 83880-65-3 | Details |
| Atorvastatin Dehydro Lactone | C33H31FN2O3 | 442851-50-5 | Details |
| MoMetasone Furoate IMpurity F | C27H28Cl2O7 | 1305334-30-8 | Details |
| 1-(2-((2,4-dimethylphenyl)thio)phenyl)-4-(2-(piperazin-1-yl)phenyl) piperazine hydrochloride | C28H34N4S | 1240670-85-2 | Details |
| Mometasone | C22H28Cl2O4 | 105102-22-5 | Details |
| Lacosamide impurity I | C19H23N3O3 | 2295925-90-3 | Details |
| 4,4'-(((carbonylbis(azanediyl))bis(3-fluoro-4,1-phenylene))bis(oxy))bis(N-methylpicolinamide) | C27H22F2N6O5 | 2438857-80-6 | Details |
| 3-((3S,8R,9S,10R,13S,14S)-3-acetoxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine 1-oxide | C26H33NO3 | 2517964-85-9 | Details |
| 2,3-dimethylnaphthalene-1,4-dione | C12H10O2 | 2197-57-1 | Details |
| 2-(nicotinamido)ethyl nicotinate dihydrochloride | C8H9N3O5 | 113743-17-2 | Details |
| Regorafenib iMpurity | C14H9ClF4N2O2 | 1333390-56-9 | Details |
| 9-(1,3-Dioxolan-2-ylMethyl)-3,9-dihydro-1,3-diMethyl-1H-purine-2,6-dione | C11H14N4O4 | 1174289-18-9 | Details |
| Regorafenib impurity H | C15H14FN3O3 | 2141961-84-2 | Details |
| 4-amino-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl) tetrahydrofuran-2-yl)-6-methyl-1,3,5-triazin-2(1H)-one | C9H14N4O5 | 105330-94-7 | Details |
| 9,21-dichloro-11β-hydroxy-6α,16α-dimethyl-3,20-dioxopregna-1,4- dien-17-yl furan-2-carboxylate | C28H32Cl2O6 | 1370190-55-8 | Details |
| 4-(4-(1-((4-fluorophenyl)carbamoyl)cyclopropane-1-carboxamido)phenoxy)-6,7-dimethoxyquinoline 1-oxide | C28H24FN3O6 | 1621681-63-7 | Details |
| N,N'-bis(4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)cyclopropane-1,1-dicarboxamide | C39H34N4O8 | 2439164-91-5 | Details |
| (R)-2-acetamido-N-((R)-1-(benzylamino)-3-methoxy-1-oxopropan-2-yl)-3-methoxypropanamide | Details |
| (S)-6-(2-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-1H-pyrrol-1-yl) ethyl)-5,6-dihydro-2H-pyran-2-one | Details |
| di(2,4-xylyl) disulphide | C16H18S2 | 13616-83-6 | Details |
| 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)piperidin-1-yl)-3-oxopropanenitrile | C16H20N6O | 2374700-40-8 | Details |
| 1,1'-((methylenebis(4-methoxy-3,1-phenylene))bis(2-(dimethylamino)ethane-1,1-diyl))bis(cyclohexan-1-ol) formate | Details |
| 3-((3S,4aR,5aS,6aS,6bS,9aS,11aS,11bR)-3-acetoxy-9a,11b-dimethyl- 1,2,3,4,5a,6,6a,6b,7,9a,10,11,11a,11b-tetradecahydrocyclopenta[1,2] phenanthro[8a,9-b]oxiren-9-yl)pyridine 1-oxide | Details |
| Loratadine N-Oxide | C22H23ClN2O3 | 165739-62-8 | Details |
| sodium(3R)-4-(7-(4-fluorophenyl)-7-hydroxy-1b-isopropyl-7a-phenyl1a-(phenylcarbamoyl)hexahydro-3H-oxireno[2',3':3,4]pyrrolo[2,1-b][1,3]oxazin-3-yl)-3-hydroxybutanoate | C33H35FN2O7 | 873950-17-5 | Details |
| 5-(4-bromophenyl)-6-(2-((5-bromopyrimidin-2-yl)oxy)ethoxy)pyrimidin-4-amine | C16H13Br2N5O2 | 1433875-21-8 | Details |
| (2S,3R,4S,5R,6R)-6-(acetoxymethyl)-2-(4-chloro-3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triyl triacetate | C32H37ClO12 | 1620758-21-5 | Details |
| Macitentan Impurity 2 | C10H8Br2N4O2 | 2211054-90-7 | Details |
| 1-(2-((2,4-dimethylphenyl)sulfonyl)phenyl)piperazine | C18H22N2O2S | 1639263-80-1 | Details |
| N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)-N-phenylcyclopropane-1,1-dicarboxamide | C28H25N3O5 | 849221-94-9 | Details |
| 1-((3R,5R)-6-carboxy-3,5-dihydroxyhexyl)-5-(4-fluorophenyl)-2- isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid calcium(II) | C27H30FNO6 | 1821498-27-4 | Details |
| Benzoic acid, 2-hydroxy-3-(2-phenyldiazenyl)- | C13H10N2O3 | 136819-59-5 | Details |
| n-(4-fluorophenyl)-N-(4-((7-hydroxy-6-methoxyquinolin-4-yl)oxy)phenyl)cyclopropane-1,1-dicarboxamide | C27H22FN3O5 | 1628530-42-6 | Details |
| (E)-2-hydroxy-4-(phenyldiazenyl)benzoic acid | C13H10N2O3 | 40038-46-8 | Details |
| N-((S)-1-(((R)-1-Hydroxy-3-Methylbutyl)aMino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide | C19H24N4O3 | 289472-78-2 | Details |
| IcoMethasone | C22H29ClO5 | 4647-20-5 | Details |
| 1-[2-[(2,4-diMethylphenyl)sulfinyl]phenyl]- Piperazine | C18H22N2OS | 1429908-35-9 | Details |
| APST-ZA | C20H22N2O6S | 635705-72-5 | Details |
| 2-(1a-methyl-6-oxo-3-phenoxy-1,1a,6,6a-tetrahydroindeno[1,2-b]azirine-6a-carboxamido)acetic acid | C19H16N2O5 | 2301113-15-3 | Details |
| N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-2-amine | C20H25N5 | 2374700-38-4 | Details |
| 3-((3R,4R)-3-(7H-[4,7'-bipyrrolo[2,3-d]pyrimidin]-4'-yl(methyl) amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile | C22H23N9O | 2504210-48-2 | Details |
| (R)-2-amino-N-benzyl-3-methoxypropanamide hydrochloride | Details |
| 2-chloro-1,4-bis(chloromethyl)benzene | C8H7Cl3 | 10221-08-6 | Details |
| N-((S)-1-(((S)-1-hydroperoxy-3-methylbutyl)amino)-1-oxo-3-phenyl propan-2-yl)pyrazine-2-carboxamide | C19H24N4O4 | 886979-81-3 | Details |
| 1-((4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)carbamoyl)cyclopropane-1-carboxylic acid | C22H20N2O6 | 849217-77-2 | Details |
| Menadione | C11H8O2 | 58-27-5 | Details |
| Fluticasone propionate impurity 02 | Details |
| 21-CHLORO-9-BETA,11-BETA-EPOXY-17-HYDROXY-16-ALPHA-METHYLPREGNA-1,4-DIENE-3,20-DIONE | C22H27ClO4 | 83881-08-7 | Details |
| (R)-2-amino-N-benzyl-3-hydroxypropanamide hydrochloride | C10H14N2O2 | 175481-39-7 | Details |
| 6-AMino-5-azacytidine | C8H13N5O5 | 105331-00-8 | Details |
| 1-(2-((2,6-dimethylphenyl)thio)phenyl)piperazine hydrochloride | C18H22N2S | 508233-76-9 | Details |
| Dapagliflozin Impurity 10 | C21H25ClO7 | 960404-86-8 | Details |
| 4-PHENYLAZOPHENOL | C12H10N2O | 1689-82-3 | Details |
| Mometasone Furoate Impurity 18 | Details |
| Cabozantinib Impurity EXA | C17H14F2N2O2 | 1431468-36-8 | Details |
| N-(4-fluorophenyl)-N-(4-((6-hydroxy-7-methoxyquinolin-4-yl)oxy)phenyl)cyclopropane-1,1-dicarboxamide | C27H22FN3O5 | 1628530-47-1 | Details |
| Dispiro[11H-benzo[5,6]cyclohepta[1,2-b]pyridine-11,2'-oxirane-3',4''-piperidine]-1''-carboxylic acid, 8-chloro-5,6-dihydro-, ethyl ester, 1-oxide | C22H23ClN2O4 | 1432057-93-6 | Details |
| Isopropyl 2-Isopropylphenyl Ether | C12H18O | 14366-59-7 | Details |
| IcoMethasone 21-Acetate | C24H31ClO6 | 24916-91-4 | Details |
| 4-(2-((2,4-dimethylphenyl)thio)phenyl)piperazine-1-carbaldehyde | C19H22N2OS | 2135576-73-5 | Details |
| 1-(4-((2,4-dimethylphenyl)thio)phenyl)piperazine hydrochloride | C18H22N2S | 1815608-51-5 | Details |
| 4-(3-fluoro-4-((2-(methylcarbamoyl)pyridin-4-yl)amino)phenoxy)-Nmethylpicolinamide formate | C20H18FN5O3 | 1855006-12-0 | Details |
| Mometasone Furoate EP Impurity R | C28H33ClO9S | 1370190-08-1 | Details |
| Macitentan Impurity 33 | C28H32Br2N8O6S2 | 2089065-77-8 | Details |
| Macitentan Hydroxy amine Impurity | C12H12BrN3O2 | 2211059-05-9 | Details |
| 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoic acid | C16H21N5O3 | 2328165-36-0 | Details |
| Phenol, 2-(2-phenyldiazenyl)- | C12H10N2O | 2362-57-4 | Details |
| (2R/S,3S/R)-3-(6-bromo-5-fluoropyrimidin-4-yl)-2-(2,4-difluorophenyl) -1-(1H-1,2,4-triazol-1-yl)butan-2-ol | C16H13BrF3N5O | 1307315-04-3 | Details |
| (S)-2-((1r,3R,5R,7S)-3-hydroxyadamantan-1-yl)-1-iminohexahydro pyrrolo[1,2-a]pyrazin-4(1H)-one hydrochloride | Details |
| 2H-Isoindole-2-butanoic acid, 4-amino-γ-(aminocarbonyl)-1,3-dihydro-1,3-dioxo-, (γS)- | C13H13N3O5 | 918314-44-0 | Details |
| AZOBENZENE-3-CARBOXYLICACID | C13H10N2O2 | 14474-22-7 | Details |
| N-((S)-1-(((R)-1-hydroperoxy-3-methylbutyl)amino)-1-oxo-3-phenyl propan-2-yl)pyrazine-2-carboxamide | C19H24N4O4 | 886979-78-8 | Details |
| N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d] pyrimidin-2-amine | C13H19N5 | 2374700-39-5 | Details |
| PROPOFOL RELATED COMPOUND C (50 MG) (2,6-DIISOPROPYLPHENYL ISOPROPYLETHER) | C15H24O | 141214-18-8 | Details |
| Pyridine, 3-(3-ethoxyandrosta-5,16-dien-17-yl)- | C26H35NO | 2484719-14-2 | Details |
| (Z)-2-((S)-2-cyanopyrrolidin-1-yl)-N-((1r,3R,5R,7S)-3-hydroxy adamantan-1-yl)-2-oxoethan-1-imine oxide | C7H10ClNO3 | 23500-10-9 | Details |
| (S)-2-Acetamido-N-benzyl-3-methoxypropanamide | C13H18N2O3 | 175481-37-5 | Details |
| N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-2,2'-dichloro-N-methyl-7H-[4,7'-bipyrrolo[2,3-d]pyrimidin]-4'-amine | C26H26Cl2N8 | 2459302-87-3 | Details |
| Mometasone Furoate EP Impurity M | C22H29ClO4 | 57780-86-6 | Details |
| 1-(chloromethyl)-4-(dichloromethyl)benzene | C8H7Cl3 | 7398-44-9 | Details |
| INDEX NAME NOT YET ASSIGNED | C16H16FN3O4 | 2514957-39-0 | Details |
| (1S,5R)-9-(4-fluorophenyl)-11-isopropyl-10-phenyl-1,2,6,7-tetrahydro-3H,5H-1,5-methanopyrrolo[1,2-e][1,5]oxazonin-3-one | Details |
| 3-Hydroxyazobenzene | 2437-11-8 | Details |
| Desmethyl Lacosamide | C12H16N2O3 | 175481-38-6 | Details |
| 11,17-Difuroate MoMetasone Furoate | C32H32Cl2O8 | 1370190-33-2 | Details |
| IcoMethasone 21-Mesylate | C23H31ClO7S | 352315-75-4 | Details |
| N-(5-(4-bromophenyl)-6-(2-((5-bromopyrimidin-2-yl)oxy)ethoxy)pyrimidin-4-yl)methanesulfonamide | C17H15Br2N5O4S | 556796-88-4 | Details |
| Mometasone Furoate EP Impurity S | C27H30Cl2O6 | 2231764-75-1 | Details |
| Gadobutrol Impurity 10 | Details |
| Loratadine Impurity 19 | C22H24N2O2 | 79779-58-1 | Details |
| 1,3-bis((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)propane-1,3-dione | C29H38N10O2 | 2504210-41-5 | Details |
| 3-((3R,4R)-4-methyl-3-(methyl(7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile | C23H26N6O3S | 2259288-22-5 | Details |
| ((2R,3S,4R,5R,6S)-6-(4-chloro-3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)methyl acetate | C25H29ClO8 | 2452301-09-4 | Details |
| 6ξ-acetoxy-9,21-dichloro-11β-hydroxy-16α-methyl-3,20- dioxo-5ξ-pregn-1-en-17-yl furan-2-carboxylate | Details |
| Product Total： Product Page： | ||||
| 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 | ||||